Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, US

Chairman of the Board

Senior Vice President, Finance and Chief Accounting Officer

Senior Vice President, Human Resources and Facilities Operations

Senior Vice President, Technology Assessment and Quality Assurance

Nektar Therapeutics has offices in San Francisco, Huntsville and Hyderabad

San Francisco, US (HQ)

455 Mission Bay Boulevard South

Hyderabad, IN

Sy.Nos.101/2 Genome Valley Lalgadi Malakpet Shameerpet Mandal Rangareddy District Hyderabad

Huntsville, US

1112 Church Street

Nektar Therapeutics's revenue was reported to be $24.7 m in Q1, 2017

USD

## Revenue (Q1, 2017) | 24.7 m |

## Gross profit (Q1, 2017) | 18.6 m |

## Gross profit margin (Q1, 2017), % | 75% |

## Net income (Q1, 2017) | (63.9 m) |

## EBIT (Q1, 2017) | (54.4 m) |

## Market capitalization (17-Aug-2017) | 2.9 b |

## Cash (31-Mar-2017) | 23.5 m |

Nektar Therapeutics's current market capitalization is $2.9 b.

USD | FY, 2013^{} | FY, 2014^{} | Y, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 148.9 m | 200.7 m | 230.8 m | 165.4 m |

## Revenue growth, % | 35% | 15% | (28%) | |

## Cost of goods sold | 38.5 m | 28.5 m | 34.1 m | 30.2 m |

## Gross profit | 110.4 m | 172.2 m | 196.7 m | 135.2 m |

## Gross profit Margin, % | 74% | 86% | 85% | 82% |

## R&D expense | 203.8 m | |||

## General and administrative expense | 44.3 m | |||

## Operating expense total | 230.5 m | 188.7 m | 260.2 m | 278.3 m |

## EBIT | (120.1 m) | (16.5 m) | (29.4 m) | (112.9 m) |

## EBIT margin, % | (81%) | (8%) | (13%) | (68%) |

## Interest expense | 18.5 m | 17.9 m | 18.3 m | 22.5 m |

## Interest income | 732 k | 814 k | ||

## Pre tax profit | (159.8 m) | |||

## Income tax expense | 2.2 m | (512 k) | 506 k | 876 k |

## Net Income | (162 m) | (53.9 m) | (81.2 m) | (153.5 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 28.5 m | 132.9 m | 108.8 m | 22.7 m | 60 m | 58.9 m | 32.8 m | 36.3 m | 24.7 m |

## Cost of goods sold | 5.1 m | 9.2 m | 8.4 m | 10.5 m | 6.8 m | 8.9 m | 7.7 m | 7 m | 6.1 m |

## Gross profit | 23.4 m | 123.7 m | 100.4 m | 12.1 m | 53.2 m | 50 m | 25.1 m | 29.3 m | 18.6 m |

## Gross profit Margin, % | 82% | 93% | 92% | 54% | 89% | 85% | 76% | 81% | 75% |

## R&D expense | 36.7 m | 34.2 m | 47 m | 45.4 m | 43.2 m | 49.3 m | 52.4 m | 52 m | 61.1 m |

## General and administrative expense | 9.6 m | 9.1 m | 10.3 m | 10.2 m | 9.5 m | 10.2 m | 11 m | 10.3 m | 12 m |

## Operating expense total | 46.3 m | 43.3 m | 57.3 m | 55.6 m | 52.8 m | 59.5 m | 63.4 m | 62.2 m | 73 m |

## EBIT | (22.9 m) | 80.3 m | 43 m | (43.5 m) | 419 k | (9.5 m) | (38.3 m) | (32.9 m) | (54.4 m) |

## EBIT margin, % | (80%) | 60% | 40% | (192%) | 1% | (16%) | (117%) | (91%) | (220%) |

## Interest expense | (4.5 m) | (4.4 m) | (4.2 m) | (4.1 m) | (4.2 m) | (5.7 m) | (5.6 m) | (5.6 m) | (5.4 m) |

## Interest income | 132 k | 133 k | |||||||

## Pre tax profit | (32.4 m) | (52.5 m) | (48.5 m) | (43.1 m) | (63.7 m) | ||||

## Income tax expense | 195 k | 248 k | 213 k | 164 k | 92 k | 167 k | 127 k | 139 k | 133 k |

## Net Income | (32.6 m) | 70.6 m | 33.8 m | (52.7 m) | (8.2 m) | (19.5 m) | (48.6 m) | (43.2 m) | (63.9 m) |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 39.1 m | 12.4 m | 55.6 m | 59.6 m |

## Inventories | 13.5 m | 13 m | 11.3 m | 11.1 m |

## Current Assets | 257.9 m | 288.2 m | 350.1 m | 426.3 m |

## PP&E | 67 m | 70.4 m | 71.3 m | 65.6 m |

## Goodwill | 76.5 m | 76.5 m | 76.5 m | 76.5 m |

## Total Assets | 434.5 m | 441.6 m | 502.1 m | 568.9 m |

## Accounts Payable | 9.1 m | 2.7 m | 2.4 m | 2.8 m |

## Current Liabilities | 98.2 m | 64 m | 61.2 m | 72.2 m |

## Total Liabilities | 480.7 m | |||

## Additional Paid-in Capital | 1.6 b | 1.8 b | 1.9 b | 2.1 b |

## Retained Earnings | (1.7 b) | (1.8 b) | (1.9 b) | (2 b) |

## Total Equity | (89.9 m) | 36.3 m | 6.4 m | 88.1 m |

## Financial Leverage | -4.8 x | 12.2 x | 78.1 x | 6.5 x |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Cash | 30.7 m | 32 m | 129.5 m | 20.9 m | 18.8 m | 72.5 m | 55.7 m | 63.3 m | 23.5 m |

## Accounts Receivable | 3 m | 46.1 m | 2.9 m | 3.7 m | 3 m | 39.7 m | 27.8 m | 14.2 m | 1.6 m |

## Inventories | 14.1 m | 11.7 m | 12.5 m | 10.1 m | 10.4 m | 11.3 m | 10.3 m | 10.8 m | 13 m |

## Current Assets | 298.2 m | 324.1 m | 347.3 m | 302.2 m | 286.4 m | 344.8 m | 318.3 m | 282.5 m | 381 m |

## PP&E | 71.1 m | 69.3 m | 69.3 m | 72.2 m | 72.5 m | 69.9 m | 67.8 m | 65.6 m | 66.6 m |

## Goodwill | 76.5 m | 76.5 m | 76.5 m | 76.5 m | 76.5 m | 76.5 m | 76.5 m | 76.5 m | 76.5 m |

## Total Assets | 478.1 m | 476.9 m | 499.2 m | 456.7 m | 449.2 m | 491.9 m | 463.1 m | 425.1 m | 528.5 m |

## Accounts Payable | 7.4 m | 5.4 m | 5 m | 2.8 m | 2.3 m | 2.3 m | 2.3 m | 7.1 m | 7 m |

## Current Liabilities | 84.4 m | 80.5 m | 75.4 m | 81.1 m | 208.1 m | 65.9 m | 79.3 m | 76.3 m | 78.5 m |

## Additional Paid-in Capital | 1.8 b | 1.8 b | 1.8 b | 1.8 b | 1.9 b | 1.9 b | 1.9 b | 1.9 b | 2.1 b |

## Retained Earnings | (1.8 b) | (1.7 b) | (1.8 b) | (1.8 b) | (1.8 b) | (1.9 b) | (1.9 b) | (2 b) | (2.1 b) |

## Total Equity | (35.4 m) | 47.2 m | 77.3 m | 35.1 m | 39.1 m | (275 k) | (39.3 m) | (67.9 m) | 44.7 m |

## Financial Leverage | -13.5 x | 10.1 x | 6.5 x | 13 x | 11.5 x | -1788.7 x | -11.8 x | -6.3 x | 11.8 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | (162 m) | (53.9 m) | (81.2 m) | (153.5 m) |

## Depreciation and Amortization | 14.3 m | 12.9 m | 12.9 m | 15.4 m |

## Accounts Receivable | 3.6 m | (1.4 m) | (16 m) | 4.3 m |

## Inventories | 4.8 m | 500 k | 1.6 m | 237 k |

## Accounts Payable | 6.2 m | (6.4 m) | (412 k) | 518 k |

## Cash From Operating Activities | (38.5 m) | (142 m) | (73.1 m) | (117 m) |

## Purchases of PP&E | (4.1 m) | (10 m) | (11.2 m) | (6.4 m) |

## Cash From Investing Activities | 49.9 m | (37.6 m) | (14.3 m) | (82.4 m) |

## Cash From Financing Activities | 2.2 m | 153 m | 130.8 m | 203.6 m |

## Interest Paid | 17.6 m | 17.4 m | 20.2 m | 20.6 m |

## Income Taxes Paid | 1 m | 964 k | 860 k | 757 k |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (32.6 m) | 70.6 m | 33.8 m | (52.7 m) | (8.2 m) | (19.5 m) | (48.6 m) | (43.2 m) | (63.9 m) |

## Depreciation and Amortization | 3 m | ||||||||

## Accounts Receivable | 3 m | 46.1 m | 722 k | 3.7 m | 3 m | 39.7 m | 27.8 m | 14.2 m | 1.6 m |

## Inventories | 14.1 m | 11.7 m | 441 k | 10.1 m | 10.4 m | 11.3 m | 10.3 m | 10.8 m | 13 m |

## Accounts Payable | 7.4 m | 5.4 m | 2.2 m | 2.8 m | 2.3 m | 2.3 m | 2.3 m | 7.1 m | 7 m |

## Cash From Operating Activities | 63.3 m | ||||||||

## Purchases of PP&E | (1.1 m) | ||||||||

## Cash From Investing Activities | 53.2 m | ||||||||

## Cash From Financing Activities | 587 k | ||||||||

## Interest Paid | 7.9 m |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 52.8 k |

## Financial Leverage | 11.8 x |